18 Dec 2020 ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic Member news
18 Dec 2020 Imec presents smallest finFET-based biosensor for high-sensitivity molecule detection Member news
16 Dec 2020 Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib) Member news
16 Dec 2020 Mithra announces positive DSMB safety review and continuation of its Phase III Clinical Program Donesta® in menopause Member news
08 Dec 2020 OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform Member news
03 Dec 2020 Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease Member news
02 Dec 2020 eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities Member news
02 Dec 2020 AbolerIS Pharma signed with Ouest Valorisation an exclusive world-wide license to develop new first-in-class anti-CD45RC monoclonal antibodies Member news
01 Dec 2020 atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
